NCT02750280View on ClinicalTrials.gov

A Longitudinal Study to Evaluate an Extracellular Matrix (MatriStem®) for the Treatment of Diabetic Foot Ulcers

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Neuropathic Diabetic Foot Ulcer
Interventions
DEVICE

MatriStem® [Urinary Bladder Matrix (UBM)]

Porcine derived urinary bladder extracellular matrix

DEVICE

Mepilex® [Silicone foam dressing]

primary wound dressing

Trial Locations (1)

10461

Calvary Hospital Center for Curative and Palliative Wound Care, The Bronx

Sponsors
All Listed Sponsors
collaborator

Integra LifeSciences Corporation

INDUSTRY

lead

Calvary Hospital, Bronx, NY

OTHER

NCT02750280 - A Longitudinal Study to Evaluate an Extracellular Matrix (MatriStem®) for the Treatment of Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter